BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8808022)

  • 1. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    Am J Health Syst Pharm; 1996 Feb; 53(3):274-8. PubMed ID: 8808022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    J Healthc Resour Manag; 1996 Sep; 14(7):14-9. PubMed ID: 10161585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formularies in integrated health systems: Integris health.
    Osborne JA
    Am J Health Syst Pharm; 1996 Feb; 53(3):278-80. PubMed ID: 8808023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formularies in integrated health systems: Fallon Healthcare System.
    Cano SB
    Am J Health Syst Pharm; 1996 Feb; 53(3):270-3. PubMed ID: 8808021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System.
    Radomski TR; Good CB; Thorpe CT; Zhao X; Marcum ZA; Glassman PA; Lowe J; Mor MK; Fine MJ; Gellad WF
    J Manag Care Spec Pharm; 2016 Feb; 22(2):114-20. PubMed ID: 27015250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a formulary management process.
    Karel LI; Delisle DR; Anagnostis EA; Wordell CJ
    Am J Health Syst Pharm; 2017 Aug; 74(16):1245-1252. PubMed ID: 28790076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider perceptions of pharmacy management: lessons from the military health system.
    Glassman PA; Tanielian T; Harris K; Suarez A; Bradley M; Atkinson SW; Davies W; Williams T
    Med Care; 2004 Apr; 42(4):361-6. PubMed ID: 15076813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.